IRWD insider transaction filings
IRONWOOD PHARMACEUTICALS INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-22. Screen IRWD transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-22 | 4 | Silber Jeffrey — SVP, CMO, Head-Res&Drug | Grant/award (A): 137,036 @ $0 | EDGAR |
| 2026-07-09 | 4 | Silver Ronald — PFO & PAO | Sale (S): 127,890 @ $4.52 | EDGAR |
| 2026-06-17 | 4 | Shepard Jay — Director | Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-06-17 | 4 | Kessler Marla L — Director | Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-06-17 | 4 | Currie Mark G — Director | Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-06-17 | 4 | Duane Jon R — Director | Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-06-17 | 4 | McHugh Julie — Director | Grant/award (A): 63,481 @ $0 · Sale (S): 21,571 @ $3.73 | EDGAR |
| 2026-06-17 | 4 | Moukheibir Catherine — Director | Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-06-17 | 4 | DENNER ALEXANDER J — Director | Grant/award (A): 4,065 @ $0 · Grant/award (A): 63,481 @ $0 | EDGAR |
| 2026-05-21 | 4 | Silver Ronald — PFO & PAO | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-03-17 | 4 | DENNER ALEXANDER J — Director | Grant/award (A): 4,451 @ $0 · Sale (S): 6,725,000 @ $3.05 · Sale (S): 5,800 @ $3.31 | EDGAR |
| 2026-03-12 | 4 | Gaskins Tammi L — Chief Commercial Officer | Grant/award (A): 136,612 @ $0 | EDGAR |
| 2026-03-12 | 4 | Shetzline Michael — SVP, CMO, Head-Res&Drug | Grant/award (A): 136,612 @ $0 | EDGAR |
| 2026-03-12 | 4 | Silver Ronald — Principal Accounting Officer | Grant/award (A): 163,934 @ $0 | EDGAR |
| 2026-03-12 | 4 | John Minardo — Chief Legal Officer | Grant/award (A): 136,612 @ $0 | EDGAR |
| 2026-03-12 | 4 | Martini Gregory S. — Chief Financial Officer | Grant/award (A): 136,612 @ $0 | EDGAR |
| 2026-03-12 | 4 | MCCOURT Thomas A — Chief Executive Officer, Director | Grant/award (A): 409,836 @ $0 | EDGAR |
| 2026-02-25 | 4 | Martini Gregory S. — Chief Financial Officer | Sale (S): 10,487 @ $3.81 · Sale (S): 11,457 @ $3.66 | EDGAR |
| 2026-02-25 | 4 | John Minardo — Chief Legal Officer | Sale (S): 17,439 @ $3.81 · Sale (S): 19,053 @ $3.66 | EDGAR |
| 2026-02-25 | 4 | Shetzline Michael — SVP, CMO, Head-Res&Drug | Sale (S): 15,570 @ $3.81 · Sale (S): 17,012 @ $3.66 | EDGAR |
| 2026-02-25 | 4 | Gaskins Tammi L — Chief Commercial Officer | Sale (S): 10,287 @ $3.81 · Sale (S): 11,239 @ $3.66 | EDGAR |
| 2026-02-25 | 4 | MCCOURT Thomas A — Chief Executive Officer, Director | Sale (S): 94,757 @ $3.81 · Sale (S): 103,526 @ $3.66 | EDGAR |
| 2026-02-25 | 4 | Silver Ronald — Principal Accounting Officer | Sale (S): 11,552 @ $3.81 · Sale (S): 12,621 @ $3.66 | EDGAR |
| 2026-01-07 | 4 | Silver Ronald — Principal Accounting Officer | Sale (S): 35,416 @ $4.60 | EDGAR |
| 2025-12-17 | 4 | DENNER ALEXANDER J — Director, 10% owner Sarissa Capital Management LP — 10% owner | Grant/award (A): 4,178 @ $0 | EDGAR |
| 2025-11-19 | 4 | Gaskins Tammi L — Chief Commercial Officer | Sale (S): 6,016 @ $3.32 | EDGAR |
| 2025-09-17 | 4 | DENNER ALEXANDER J — Director, 10% owner | Grant/award (A): 11,718 @ $0 | EDGAR |
| 2025-08-13 | 4 | Gaskins Tammi L — Chief Commercial Officer | Sale (S): 1,316 @ $0.84 | EDGAR |
| 2025-08-13 | 4 | John Minardo — Chief Legal Officer | Sale (S): 7,754 @ $0.84 | EDGAR |
| 2025-08-13 | 4 | Silver Ronald — Principal Accounting Officer | Sale (S): 2,846 @ $0.84 | EDGAR |
| 2025-08-13 | 4 | Martini Gregory S. — Chief Financial Officer | Sale (S): 1,265 @ $0.84 | EDGAR |
| 2025-06-17 | 4 | DENNER ALEXANDER J — Director, 10% owner Sarissa Capital Management LP — 10% owner | Grant/award (A): 24,193 @ $0 | EDGAR |
| 2025-06-12 | 4 | Kessler Marla L — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | Shepard Jay — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | Moukheibir Catherine — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | Duane Jon R — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | Currie Mark G — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | McHugh Julie — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | Dreyfus Andrew — Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-06-12 | 4 | DENNER ALEXANDER J — Director, 10% owner Sarissa Capital Management LP — 10% owner | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-05-20 | 4 | MCCOURT Thomas A — Chief Executive Officer, Director | Sale (S): 13,353 @ $0.58 · Grant/award (A): 540,000 @ $0 | EDGAR |
| 2025-05-20 | 4 | Gaskins Tammi L — Chief Commercial Officer | Sale (S): 2,563 @ $0.58 | EDGAR |
| 2025-04-04 | 4 | DENNER ALEXANDER J — Director, 10% owner Sarissa Capital Management LP — 10% owner | Grant/award (A): 10,416 @ $0 | EDGAR |
| 2025-02-12 | 4 | MCCOURT Thomas A — Chief Executive Officer, Director | Sale (S): 139,064 @ $1.76 | EDGAR |
| 2025-02-12 | 4 | Silver Ronald — Principal Accounting Officer | Sale (S): 12,048 @ $1.76 | EDGAR |
| 2025-02-12 | 4 | Shetzline Michael — SVP, CMO, Head-Res&Drug | Grant/award (A): 133,333 @ $0 · Sale (S): 41,269 @ $1.76 | EDGAR |
| 2025-02-12 | 4 | John Minardo — Chief Legal Officer | Grant/award (A): 122,222 @ $0 · Sale (S): 38,938 @ $1.76 | EDGAR |
| 2025-02-12 | 4 | Martini Gregory S. — Chief Financial Officer | Sale (S): 12,052 @ $1.76 | EDGAR |
| 2025-01-29 | 4 | Silver Ronald — Principal Accounting Officer | Grant/award (A): 133,333 @ $0 | EDGAR |
| 2025-01-29 | 4 | Martini Gregory S. — Chief Financial Officer | Grant/award (A): 111,111 @ $0 | EDGAR |
Recent 8-K events — IRONWOOD PHARMACEUTICALS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-21 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-02 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IRWD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →